Silexion Therapeutics Corp - 10-Q Filing
Silexion Therapeutics reports Q3 2026 results featuring a 1-for-10 reverse share split and significant equity activity including inducement offers and warrant issuances.
Tickers: $SLXN
More Regulatory news
- Gores Holdings XI, Inc. - 10-Q Filing
- Peraso Inc. - 8-K Filing
- SOLESENCE, INC. - 10-Q Filing
- BioRestorative Therapies, Inc. - 8-K Filing
- Jaws Mustang Acquisition Corp - 10-Q Filing
- Private Bancorp of America, Inc. - 10-Q Filing
- USA Rare Earth, Inc. - 10-Q Filing
- SCHWAB CHARLES CORP - 8-K Filing
- SPRUCE POWER HOLDING CORP - 8-K Filing
- Xterax Corp II - 10-Q Filing